- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03504215
Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.
Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators postulate that a 14-week exercise intervention will improve exercise capacity in preterm adults, as seen in other at-risk populations, in correlation with measures of vascular health, heart and muscle perfusion and oxygenation, and pulmonary function detected by cutting edge and highly sensitive imaging and circulating biomarkers. These markers are more sensitive to pre-disease changes than traditional health measures, and are largely unexplored in preterm populations.
The investigators will:
- Determine whether a 14-week supervised exercise training improves exercise capacity in young adults (18-29 years old) born very preterm at <29 weeks gestational age.
- Examine whether improvement in exercise capacity is associated with changes in (a) markers of vascular health including circulating endothelial progenitor cells and microparticles, (b) cardiac perfusion by cutting-edge oxygenation-sensitive cardiovascular magnetic resonance imaging (MRI), (c) lung regional ventilation measured by newly developed hydrogen proton (1H) MRI, (d) muscle oxygenation during exercise.
- Compare the response of the above measures to exercise intervention between young adults born very preterm and term controls.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montréal, Quebec, Canada, H3T1C5
- St. Justine's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Both groups :
- Aged between 18-29 years old
- Less than 120 minutes of exercise per week
- Willingness to be part of the 14 weeks exercise intervention
Preterm group:
- Born under 29 weeks of gestation
Term group :
- Born between 37-41 weeks
- Appropriate weight fo gestational weight
Exclusion Criteria:
- Pregnancy
- conditions excludins individual from exercise
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: young adults
Both young adults born preterm (n=60) and term (n=30) will undergo the exercise intervention.
|
Assigned intervention : 14-week supervised intervention of aerobic and resistance training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
|
Respiratory exchange ratio (RER) (%)
|
16 weeks
|
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
|
Oxygen uptake (VO2max) (mL/min)
|
16 weeks
|
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
|
Carbon dioxide production (VCO2) (L/min)
|
16 weeks
|
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
|
VO2peak (mL/kg/min)
|
16 weeks
|
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
|
Weight (kg)
|
16 weeks
|
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
|
Height (cm)
|
16 weeks
|
Measurement of the peak oxygen consumption before and after the physical intervention
Time Frame: 16 weeks
|
Age (years)
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiac oxygen sensitive MRI (OS-MRI)
Time Frame: 18 weeks
|
myocardial perfusion in response to CO2 modulation
|
18 weeks
|
Lung regional ventilation using a 3D proton MRI ultrashort ecotime
Time Frame: 1 week
|
Parenchyma signal intensity (SI)
|
1 week
|
Muscle oxygenation
Time Frame: 18 weeks
|
Near-infrared spectroscopy (NIRS)
|
18 weeks
|
Pulmonary function
Time Frame: 18 weeks
|
Forced spirometry (FEV1, L)
|
18 weeks
|
Pulmonary function
Time Frame: 18 weeks
|
Forced spirometry (FVC, L)
|
18 weeks
|
Pulmonary function
Time Frame: 18 weeks
|
Forced spirometry (FEF25-75, L/s)
|
18 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anne Monique Nuyt, MD, St. Justine's Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HAPI Fit Clinical Study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prematurity; Extreme
-
University of WashingtonNational Institute of Neurological Disorders and Stroke (NINDS)CompletedExtreme PrematurityUnited States
-
Guilherme Sant'Anna, MDCompleted
-
Level 42 AI, Inc.Georgetown UniversityRecruitingPremature Birth | Prematurity | Premature Lungs | Prematurity; ExtremeUnited States
-
Radboud University Medical CenterUniversity Medical Center Groningen; UMC Utrecht; Erasmus Medical Center; Amsterdam... and other collaboratorsCompletedComplications | Extreme Prematurity
-
Assistance Publique - Hôpitaux de ParisRecruitingNewborn | Extreme Prematurity | Pretrm InfantsFrance
-
University of North Carolina, Chapel HillNational Center for Advancing Translational Sciences (NCATS)CompletedParent-Child Relations | Parents | Extreme PrematurityUnited States
-
Christiana Care Health ServicesProvidence Health & ServicesCompletedPregnancy Preterm | Birth, Preterm | Extreme PrematurityUnited States
-
Sharp HealthCareThrasher Research FundTerminatedExtreme Prematurity - Less Than 28 WeeksUnited States, Spain, United Kingdom, Slovenia, Austria, Sweden, Ireland, Poland, Italy, France, Germany, Russian Federation
-
Hôpital de la Croix-RousseCompletedGrowth Retardation | Prematurity; ExtremeFrance
Clinical Trials on Exercise Intervention
-
VA Office of Research and DevelopmentRecruitingMobility Impairment | Asymptomatic Carotid Stenosis (50-69%)United States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of AarhusNot yet recruiting
-
Glasgow Caledonian UniversityUnknown
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
Sheffield Hallam UniversitySheffield Teaching Hospitals NHS Foundation TrustCompletedQuality of Life | Systemic Sclerosis | Raynaud's PhenomenonUnited Kingdom
-
VA Office of Research and DevelopmentCompletedHeart FailureUnited States
-
University Medical Center GroningenDutch Kidney Foundation; Innovation Fund of the Dutch Medical Insurance CompaniesCompletedMetabolic Syndrome | Kidney Transplant | Post-transplant Weight GainNetherlands
-
Istanbul UniversityCompletedGlenohumeral ArthritisTurkey
-
Aristotle University Of ThessalonikiCompleted